Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Down 24.5% in December

Basel Medical Group Ltd (NASDAQ:BMGL) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totaling 150,845 shares, a decrease of 24.5% from the December 15th total of 199,691 shares. Approximately 0.8% of the company’s shares are sold short. Based on an average daily trading volume, of 75,100 shares, the short-interest ratio is currently 2.0 days. Based on an average daily trading volume, of 75,100 shares, the short-interest ratio is currently 2.0 days. Approximately 0.8% of the company’s shares are sold short.

Institutional Investors Weigh In On Basel Medical Group

Several institutional investors and hedge funds have recently modified their holdings of BMGL. Citadel Advisors LLC acquired a new stake in shares of Basel Medical Group in the third quarter valued at about $169,000. Vanguard Personalized Indexing Management LLC purchased a new position in Basel Medical Group in the 3rd quarter worth approximately $40,000. Virtu Financial LLC grew its position in Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after acquiring an additional 17,608 shares in the last quarter. Finally, Marex Group plc purchased a new stake in shares of Basel Medical Group during the second quarter valued at approximately $25,000.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Basel Medical Group in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Basel Medical Group Trading Down 0.1%

BMGL opened at $0.83 on Monday. Basel Medical Group has a 52-week low of $0.49 and a 52-week high of $9.40. The company has a 50 day moving average of $0.90 and a two-hundred day moving average of $1.57.

Basel Medical Group (NASDAQ:BMGL) last issued its earnings results on Monday, November 17th. The company reported ($0.25) EPS for the quarter. The firm had revenue of $2.60 million for the quarter.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.